quinolinic acid and minocycline

quinolinic acid has been researched along with minocycline in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bezard, E; Diguet, E; Gross, CE; Stefanova, N; Tison, F; Wenning, GK1
Bantubungi, K; Blum, D; Brotchi, J; Brouillet, E; Chtarto, A; Déglon, N; Galas, MC; Greco, A; Jacquard, C; Levivier, M; Minghetti, L; Pintor, A; Popoli, P; Schiffmann, SN; Tai, K; Tenenbaum, L1
Choi, HB; McLarnon, JG; Ryu, JK1
Aguado, T; Azcoitia, I; Benito, C; Carrasco, C; Fernández-Ruiz, J; Galve-Roperh, I; Guzmán, M; Julien, B; Palazuelos, J; Pazos, MR; Resel, E; Romero, J; Sagredo, O1
Chaudhary, T; Kumar, A; Mishra, J1
Bahrami, Z; Firouzi, M; Harirchian, MH; Hashemi-Monfared, A; Zahednasab, H1

Other Studies

6 other study(ies) available for quinolinic acid and minocycline

ArticleYear
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment.
    Neurology, 2004, Jan-13, Volume: 62, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Astrocytes; Clinical Trials as Topic; Corpus Striatum; Disease Models, Animal; Microglia; Minocycline; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Primates; Quinolinic Acid; Rats; Rats, Wistar; Substantia Nigra; Treatment Failure

2004
Minocycline in phenotypic models of Huntington's disease.
    Neurobiology of disease, 2005, Volume: 18, Issue:1

    Topics: Animals; Calpain; Caspases; Cell Death; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Glutamic Acid; Huntingtin Protein; Huntington Disease; Male; Minocycline; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Nitro Compounds; Nuclear Proteins; Phenotype; Propionates; Quinolinic Acid; Rats; Rats, Inbred Lew; Rats, Wistar; Staurosporine

2005
Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
    Neuroscience, 2006, Sep-15, Volume: 141, Issue:4

    Topics: Analysis of Variance; Animals; Blotting, Western; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Drug Synergism; Huntington Disease; Immunohistochemistry; Inflammation; Male; Minocycline; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase Type II; Oxidative Stress; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2006
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
    Brain : a journal of neurology, 2009, Volume: 132, Issue:Pt 11

    Topics: Animals; Anti-Bacterial Agents; Biomarkers; Corpus Striatum; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Minocycline; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Quinolinic Acid; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Seizures

2009
Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    European journal of pharmacology, 2013, Nov-15, Volume: 720, Issue:1-3

    Topics: Animals; Behavior, Animal; Brain; Caspase 3; Disease Models, Animal; Drug Synergism; Electron Transport Complex IV; Glutathione; Hesperidin; Huntington Disease; Male; Maze Learning; Minocycline; Motor Activity; Neuroprotective Agents; Nitrites; Quinolinic Acid; Quinone Reductases; Rats; Rats, Wistar; Succinate Dehydrogenase; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2013
The effect of minocycline on indolamine 2, 3 dioxygenase expression and the levels of kynurenic acid and quinolinic acid in LPS-activated primary rat microglia.
    Cytokine, 2018, Volume: 107

    Topics: Animals; Brain; Cell Survival; Cells, Cultured; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Kynurenic Acid; Lipopolysaccharides; Microglia; Minocycline; Neuroglia; Quinolinic Acid; Rats; Rats, Wistar

2018